Global Hemostats Market valued at $2.7 billion in 2021, is set to witness a decent growth of 6% by 2026
Hemostasis is the body’s natural reaction to an injury that stops bleeding and repairs the damage. The capability helps in conserving blood and prevents infection. Hemostats are surgical tools that are used in surgical procedures to control bleeding. Technological Advancements are driving the Hemostats Market Growth Uncontrollable bleeding poses substantial fatality risks and costs in the battlefield, emergency, and hospital settings. To address these concerns, players operating in the market are focusing on developing hemostatic agents that can rapidly control bleeding, possess antibacterial properties, can be used as adjuncts to control bleeding during surgical procedures, and control residual problematic bleeding if conventional methods fail. In Feb 2022, Futura Surgicare Pvt Ltd. ’s new vertical Dolphin Hemostats launched hemostatic products under the brand Hemostax (Oxidised Regenerated Cellulose). Hemostax Standard is an absorbable hemostat that is designed to help surgeons ...